Patents by Inventor Tao Wang

Tao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040023982
    Abstract: The present invention is directed to a series of chemical entitites that express HIV-1 inhibitory activities.
    Type: Application
    Filed: July 16, 2003
    Publication date: February 5, 2004
    Inventors: Tao Wang, Owen B. Wallace, Zhongxing Zhang, Nicholas A. Meanwell, John A. Bender
  • Publication number: 20040022024
    Abstract: A cooling hood for a circuit board is provided. The circuit board includes at least one semiconductor device. The cooling hood includes a duct mounted onto the circuit board and surrounding at least a portion of the semiconductor device. The duct forms an inlet and an outlet. A cooling medium enters the duct through the inlet and exits the duct through the outlet.
    Type: Application
    Filed: July 31, 2002
    Publication date: February 5, 2004
    Applicant: Infineon Technologies North America Corp.
    Inventors: Thoai-Thai Le, Guenter Gerstmeier, David SuitWai Ma, Tao Wang
  • Publication number: 20040009556
    Abstract: Genes have been identified in the Bacillus genome that are responsive to various metabolic conditions and growth cycle changes. The new responsiveness of these genes allows for their use in regulated gene expression in Bacillus sp. and for the monitoring of bioreactor health.
    Type: Application
    Filed: June 24, 2003
    Publication date: January 15, 2004
    Inventors: Laura A. Bedzyk, Tao Wang, Rick W. Ye
  • Publication number: 20040009985
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: March 20, 2003
    Publication date: January 15, 2004
    Inventors: Tao Wang, Owen B. Wallace, Nicholas A. Meanwell, John F. Kadow, Zhongxing Zhang, Zhong Yang
  • Publication number: 20030236277
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: January 27, 2003
    Publication date: December 25, 2003
    Inventors: John F. Kadow, Qiufen May Xue, Tao Wang, Zhongxing Zhang, Nicholas A. Meanwell
  • Patent number: 6649789
    Abstract: A process for the vapor phase preparation of vinyl acetate in the presence of a catalyst of 0.2 to 1.3% by weight of gold or a gold compound, 0.3 to 10% by weight of an alkali metal compound, 0.5 to 2.0% by weight of a palladium compound and 0.01 to 1% by weight of a lanthanoid compound.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: November 18, 2003
    Assignee: Celanese Chemicals Europe GmbH
    Inventors: Bernhard Herzog, Tao Wang, Toan Nicolau
  • Publication number: 20030207910
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: August 7, 2002
    Publication date: November 6, 2003
    Inventors: Tao Wang, Zhongxing Zhang, Nicholas A. Meanwell, John F. Kadow, Zhiwei Yin, Qiufen May Xue
  • Patent number: 6632819
    Abstract: The invention comprises compounds of the class of azaindole piperazine diamide derivatives, compositions thereof and their use as anti-viral agents, and particularly for treating HIV infection.
    Type: Grant
    Filed: October 10, 2002
    Date of Patent: October 14, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Tao Wang, Owen B. Wallace, Zhongxing Zhang, Nicholas A. Meanwell, John A. Bender
  • Publication number: 20030190215
    Abstract: A fastening system is provided that includes a fastener having a pin member with a lock groove and crest geometry that is optimized to receive swaged material from collars of materials of different strengths for securing workpieces for different load applications. The lock grooves have the longest width required for collars of lower strength for one application or greater strength for a second application and the crests have the longest width required for collars of greater strength for the second application whereby satisfactory clamp and tensile loads and resistance to failure will result when the lock grooves are filled with collar materials of different strengths. The lock groove and crest geometry is of a uniform construction for the plurality of applications with pin members of a common diameter.
    Type: Application
    Filed: June 28, 2002
    Publication date: October 9, 2003
    Inventors: Thomas E. Harbin, Hai-Tao Wang, Michael U. March
  • Publication number: 20030181463
    Abstract: The present invention is directed to a series of chemical entities that express HIV-1 inhibitory activities.
    Type: Application
    Filed: October 10, 2002
    Publication date: September 25, 2003
    Inventors: Tao Wang, Owen B. Wallace, Zhongxing Zhang, Nicholas A. Meanwell, John A. Bender
  • Patent number: 6617148
    Abstract: Genes have been identified in the Bacillus genome that are responsive to various metabolic conditions and growth cycle changes. The new responsiveness of these genes allows for their use in regulated gene expression in Bacillus sp. and for the monitoring of bioreactor health.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: September 9, 2003
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Laura A. Bedzyk, Tao Wang, Rick Ye
  • Publication number: 20030166171
    Abstract: Genes have been isolated from a Methylomonas sp encoding elements of the exopolysaccharide biosynthetic pathway. The genes and gene products are the first isolated from an organisms capable of utilizing single carbon (C1) substrates as energy sources. The genes are useful for engineering other C1 utilizing microorganisms to make altered levels of exopolysaccharide which is used in a variety of commercial applications.
    Type: Application
    Filed: January 29, 2003
    Publication date: September 4, 2003
    Inventors: Mattheos Koffas, James M. Odom, Siqun Wang, Tao Wang, Rick W. Ye
  • Publication number: 20030150705
    Abstract: A method of recovering acrylic acid from a mixture comprising acrylic acid, water and acetic acid is disclosed, which includes:
    Type: Application
    Filed: December 30, 2002
    Publication date: August 14, 2003
    Inventors: Sanjeev D. Deshpande, Tao Wang, Olan Stanley Fruchey, Roger L. Roundy, Nathan K. Powell, Rafael G. Morales, Joseph E. Goins
  • Publication number: 20030148494
    Abstract: Genes have been isolated from a Methylomonas sp encoding elements of the exopolysaccharide biosynthetic pathway. The genes and gene products are the first isolated from an organisms capable of utilizing single carbon (C1) substrates as energy sources. The genes are useful for engineering other C1 utilizing microorganisms to make altered levels of exopolysaccharide which is used in a variety of commercial applications.
    Type: Application
    Filed: January 29, 2003
    Publication date: August 7, 2003
    Inventors: Mattheos Koffas, James M. Odom, Siqun Wang, Tao Wang, Rich W. Ye
  • Patent number: 6579824
    Abstract: The invention relates to a catalyst which contains palladium and/or compounds thereof, gold and/or compounds thereof, alkali metal compounds and at least one lanthanoid metal and/or compounds thereof. The invention also relates to the utilization of the catalyst in order to produce vinyl acetate from acetic acid, ethylene and oxygen or gases containing oxygen.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: June 17, 2003
    Assignees: Celanese Chemicals Europe GmbH, Celanese International Corporation
    Inventors: Bernhard Herzog, Tao Wang, Toan Nicolau
  • Patent number: 6573262
    Abstract: The invention comprises substituted indoleoxoacetic piperazine derivatives of general Formula I, compositions thereof and their use as antiviral agents, and particularly for treating HIV infection.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: June 3, 2003
    Assignee: Bristol-Myers Sqibb Company
    Inventors: Owen B. Wallace, Tao Wang, Kap-Sun Yeung, Bradley C. Pearce, Nicholas A. Meanwell, Zhilei Qiu, Haiquan Fang, Qiufen May Xue, Zhiwei Yin
  • Publication number: 20030096825
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: April 22, 2002
    Publication date: May 22, 2003
    Inventors: Tao Wang, Owen B. Wallace, Nicholas A. Meanwell, Zhongxing Zhang, John A. Bender, John F. Kadow, Kap-Sun Yeung
  • Publication number: 20030069266
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: January 2, 2002
    Publication date: April 10, 2003
    Inventors: Tao Wang, Zhongxing Zhang, Nicholas A. Meanwell, John F. Kadow, Zhiwei Yin
  • Publication number: 20030069245
    Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with indoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
    Type: Application
    Filed: December 19, 2001
    Publication date: April 10, 2003
    Inventors: Owen B. Wallace, Tao Wang, Kap-Sun Yeung, Bradley C. Pearce, Nicholas A. Meanwell, Zhilei Qiu, Haiquan Fang, Qiufen May Xue, Zhiwei Yin
  • Patent number: 6537786
    Abstract: Genes have been isolated from a Methylomonas sp encoding elements of the exopolysaccharide biosynthetic pathway. The genes and gene products are the first isolated from an organisms capable of utilizing single carbon (C1) substrates as energy sources. The genes are useful for engineering other C1 utilizing microorganisms to make altered levels of exopolysaccharide which is used in a variety of commercial applications.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: March 25, 2003
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Mattheos Koffas, James M. Odom, Siqun Wang, Tao Wang, Rick W. Ye